A review of national Veterans Health Administration data has identified how the number of glucose-lowering agents used prior to insulin initiation impacts glycemic control.
Jason A. Egge, PharmD, MS, BCPS
Advertisement
Articles by Jason A. Egge, PharmD, MS, BCPS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Emerging Data Suggest Survodutide Targets Liver Fat More Rapidly Than Weight Loss: Lee Kaplan, MD, PhD
2
Survodutide Phase 3 Data Signal Metabolic Gains Beyond Weight Loss
3
Survodutide Normalizes Liver Fat in 61% of Patients With MASLD in Phase 3 Trial: Lee Kaplan, MD, PhD
4
Bridging Science and Reality in Diabetes Care
5